Clinical Trial Update: Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating lumateperone as adjunctive therapy for major depressive disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Caplyta (lumateperone)

Snippet

Sponsor: Intra-Cellular Therapies, Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: RECRUITING